Despite its name suggesting lung cancer specificity, ALI integrates nutritional status (BMI and albumin) and systemic inflammation (neutrophil-to-lymphocyte ratio), making it potentially applicable across various cancer types. This evidence concerns the gene ALB and lung carcinoma.